Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview

In this review paper, Rodero and Crow outline the current understanding of the type I interferonopathies.

• Publication year

  2016

• Venue

  Journal of Experimental Medicine

• Publication date

  2016-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20161596PMID 27821552PMCID 5110029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood.

  2017cited by this paper
• Tartrate‐Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

  2017cited by this paper
• Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

  2016cited by this paper
• Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome

  2016cited by this paper
• Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.

  2016cited by this paper
• RNase H2 catalytic core Aicardi-Goutières syndrome–related mutant invokes cGAS–STING innate immune-sensing pathway in mice

  2016cited by this paper
• Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway

  2016cited by this paper
• Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity

  2016cited by this paper
• Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey

  2016cited by this paper
• Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation).

  2016cited by this paper
• ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters

  2016cited by this paper
• Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

  2016cited by this paper
• Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events

  2016cited by this paper
• AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

  2016cited by this paper
• Familial chilblain lupus due to a gain-of-function mutation in STING

  2016cited by this paper
• DNA polymerase-α regulates type I interferon activation through cytosolic RNA:DNA synthesis

  2016cited by this paper
• Clinical, radiological and possible pathological overlap of cystic leukoencephalopathy without megalencephaly and Aicardi-Goutières syndrome.

  2016cited by this paper
• Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome

  2016cited by this paper
• Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.

  2016cited by this paper
• Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response

  2016cited by this paper
• Unusual cutaneous features associated with a heterozygous gain‐of‐function mutation in IFIH1: overlap between Aicardi‐Goutières and Singleton‐Merten syndromes

  2015cited by this paper
• Pillars Article: Virus Interference. I. The Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 258-267.

  2015cited by this paper
• Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

  2015cited by this paper
• Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase–DNA Interaction

  2015cited by this paper
• Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity

  2015cited by this paper
• Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency

  2015cited by this paper
• Neuromyelitis optica in a child with Aicardi-GoutiÈres syndrome

  2015cited by this paper
• Aggressive CD8+ epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1

  2015cited by this paper
• USP18 lack in microglia causes destructive interferonopathy of the mouse brain

  2015cited by this paper
• A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome.

  2015cited by this paper
• Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice

  2015influential reference
• RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself

  2015cited by this paper
• Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.

  2015cited by this paper
• Phenotypic Variation in Aicardi–Goutières Syndrome Explained by Cell-Specific IFN-Stimulated Gene Response and Cytokine Release

  2015cited by this paper
• Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1

  2015cited by this paper
• Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases

  2015cited by this paper
• Type I interferonopathies: mendelian type I interferon up-regulation.

  2015cited by this paper
• Pillars Article: Virus Interference. II. Some Properties of Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 268-273.

  2015cited by this paper
• Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

  2015cited by this paper
• Nucleic Acid–Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation

  2015cited by this paper
• Aicardi–Goutières syndrome and the type I interferonopathies

  2015cited by this paper
• Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome.

  2015influential reference
• Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi–Goutières Syndrome

  2015cited by this paper
• Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

  2014influential reference
• Mutations in CECR1 associated with a neutrophil signature in peripheral blood

  2014cited by this paper
• Mutations in ADAR1, IFIH1, and RNASEH2B Presenting As Spastic Paraplegia

  2014cited by this paper
• Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations.

  2014influential reference
• The SKIV2L RNA exosome limits activation of the RIG-I-like receptors

  2014cited by this paper
• Intrinsic Self-DNA Triggers Inflammatory Disease Dependent on STING

  2014cited by this paper
• Activated STING in a vascular and pulmonary syndrome.

  2014cited by this paper
• SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

  2014cited by this paper
• Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies

  2014influential reference
• Autoimmune disorders associated with gain of function of the intracellular sensor MDA5.

  2014influential reference
• Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation

  2014influential reference
• SAMHD1‐dependent retroviral control and escape in mice

  2013cited by this paper
• SAMHD1-dependent retroviral control and escape in mice

  2013cited by this paper
• Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

  2013cited by this paper
• Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy

  2013cited by this paper
• Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.

  2013cited by this paper
• A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1

  2013cited by this paper
• Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides

  2013influential reference
• Mouse SAMHD1 Has Antiretroviral Activity and Suppresses a Spontaneous Cell-Intrinsic Antiviral Response

  2013cited by this paper
• Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti‐Interferon‐α Receptor Antibody

  2013cited by this paper
• Enzymatic Removal of Ribonucleotides from DNA Is Essential for Mammalian Genome Integrity and Development

  2012cited by this paper
• Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity

  2012cited by this paper
• Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease.

  2012cited by this paper
• Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

  2012cited by this paper
• Type I interferonopathies: a novel set of inborn errors of immunity

  2011cited by this paper
• An autoimmune disease prevented by anti-retroviral drugs

  2011cited by this paper
• Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity

  2011cited by this paper
• C1q Deficiency Leads to the Defective Suppression of IFN-α in Response to Nucleoprotein Containing Immune Complexes

  2010cited by this paper
• Autoinflammatory disease reloaded: a clinical perspective.

  2010cited by this paper
• Tartrate resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature

  2010cited by this paper
• Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response

  2009cited by this paper
• Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5

  2009influential reference
• C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.

  2009cited by this paper
• Trex1 prevents cell-intrinsic initiation of autoimmunity.

  2008influential reference
• High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus

  2007cited by this paper
• High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

  2007cited by this paper
• Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection

  2006influential reference
• Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

  2006influential reference
• Phenotypic Overlap between Infantile Systemic Lupus Erythematosus and Aicardi-Goutières Syndrome

  2005cited by this paper
• From idiopathic infectious diseases to novel primary immunodeficiencies.

  2005cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism

  2003cited by this paper
• Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

  2003cited by this paper
• Vascular Events Associated with Alpha Interferon Therapy

  2003cited by this paper
• Interferon and Aicardi-Goutières syndrome.

  2002cited by this paper
• Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B.

  2001cited by this paper
• HIV-1–related encephalopathy in infants compared with children and adults

  2000cited by this paper
• Familial Systemic Lupus Erythematosus and Congenital Infection-Like Syndrome

  2000cited by this paper
• Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α1

  1999cited by this paper
• Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha.

  1999cited by this paper
• Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

  1998cited by this paper
• The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus

  1993cited by this paper
• CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation.

  1992cited by this paper
• Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour

  1990cited by this paper
• Virus interference. I. The interferon

  1987cited by this paper
• A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis

  1984cited by this paper
• Interstitial lung disease.

  1982cited by this paper

• Interferon-Scores im Management rheumatischer Systemerkrankungen

  2026cites this paper
• USP30-AS1 functions as a post-transcriptional amplifier of interferon signalling to drive autoimmune pathogenesis.

  2026cites this paper
• Autoantibodies as Precision Tools in Connective Tissue Diseases: From Epiphenomenon to Endophenotype

  2026cites this paper
• One mutation, divergent journeys: expanding the clinical spectrum of homozygous SAMHD1 deficiency in childhood

  2026cites this paper
• Context-dependent effects of adaptive immunity on IFN-α-mediated neurotoxicity in Aicardi-Goutières syndrome.

  2026cites this paper
• Polypyrrole-Coated Microneedle Platform for Offline Electrochemical Detection of Interferon-Alpha in Interstitial Fluid.

  2026cites this paper
• ATG5 negatively regulates grass carp reovirus-induced immune-inflammatory response by degrading RIG-I and MDA5

  2025cites this paper
• A new archipelago on the horizon: type 1 interferonopathies

  2025cites this paper
• A novel STING1-activating mutation is identified in a patient with childhood-onset systemic lupus erythematosus.

  2025cites this paper
• Interferon signaling modulates Down syndrome-associated Alzheimer’s disease pathology in a mouse model

  2025cites this paper
• Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study

  2025cites this paper
• Disrupted Transcriptional Networks in Mammalian Cells Stably Over‐Expressing Pathogenic Atrophin‐1

  2025cites this paper
• Betrixaban is a broad anti-virus inhibitor by activating innate immunity

  2025cites this paper
• Z-Form Stabilization By The Zα Domain Of Adar1p150 Has Subtle Effects On A-To-I Editing

  2025cites this paper
• Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders

  2025cites this paper
• Case Report: Heterozygous ADAR c.3019G>A pathogenic variant associated with variable neurological symptoms and incomplete penetrance in a four-generational family

  2025cites this paper
• Translocating gut pathobiont Enterococcus gallinarum induces TH17 and IgG3 anti-RNA-directed autoimmunity in mouse and human.

  2025cites this paper
• Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium

  2025cites this paper
• A Wonderful Journey: The Diverse Roles of Adenosine Deaminase Action on RNA 1 (ADAR1) in Central Nervous System Diseases

  2025cites this paper
• A novel homozygous ISG15 missense variant leads to severe inflammatory skin lesions, interstitial pneumonia, and basal ganglia calcifications in a Chinese infant with ISG15 deficiency.

  2025cites this paper
• Lipid metabolism and neuroinflammation: What is the link?

  2025cites this paper
• Systemic auto-inflammatory diseases, auto-immune diseases and immune deficiencies: From independent to overlapped diseases approach.

  2025cites this paper
• USP18 is a key regulator of immune function in mouse midbrain microglia.

  2025cites this paper
• NF-κB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters

  2025cites this paper
• Supersulfides: A Promising Therapeutic Approach for Autoinflammatory Diseases

  2025cites this paper
• Liquid-liquid phase separation mediated order and pathological chaos: From cellular organization to precision modulating.

  2025cites this paper
• Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors.

  2025cites this paper
• Targeting cGAS-STING signaling and cell death modes in cancer and autoimmune diseases.

  2025cites this paper
• Disrupted Transcriptional Networks by Mutant Atrophin-1 in a Cell Culture Model of Dentatorubral-Pallidoluysian Atrophy

  2025cites this paper
• Chronic interferon-alpha overexpression induces white matter damage and neurovascular abnormalities in a mouse model of Aicardi-Goutières syndrome.

  2025cites this paper
• Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease

  2025cites this paper
• The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back.

  2024cites this paper
• The riddle of recurrent fever: a clinical approach to pediatric autoinflammatory diseases

  2024cites this paper
• MDA5 variants trade antiviral activity for protection from autoimmune disease

  2024cites this paper
• Overexpression of Egr1 Transcription Regulator Contributes to Schwann Cell Differentiation Defects in Neural Crest-Specific Adar1 Knockout Mice

  2024cites this paper
• JAK inhibition decreases the autoimmune burden in Down syndrome

  2024cites this paper
• Exploring the protective effect and mechanism of icariside II on the bladder in a rat model of radiation cystitis based on transcriptome sequencing

  2024cites this paper
• Uveitis following COVID-19 vaccination in the pediatric population: Experience at a tertiary referral hospital.

  2024cites this paper
• Childhood-inherited white matter disorders with calcification.

  2024cites this paper
• Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy

  2024cites this paper
• Idiopathic inflammatory myopathies related lung disease in adults.

  2024cites this paper
• Il bambino che ritorna perché ha sempre la febbre: capire, sapere e saper fare

  2024cites this paper
• Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus

  2024cites this paper
• Dysregulated STAT1 gain-of-function: pathogen-free autoimmunity and fungal infection

  2024cites this paper
• Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases

  2024cites this paper
• A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer.

  2024cites this paper
• Multilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: Relevance for precision therapy.

  2024cites this paper
• Harnessing cGAS–STING axis for therapeutic benefits in systemic lupus erythematosus

  2024cites this paper
• cGAS-STING pathway in systemic lupus erythematosus: biological implications and therapeutic opportunities

  2024cites this paper
• Molecular basis of autoimmune disease protection by MDA5 variants

  2024cites this paper
• IFNγ initiates TLR9-dependent autoimmune hepatitis in DNase II deficient mice

  2024cites this paper
• SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome

  2024cites this paper
• Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy

  2024cites this paper
• JAK inhibition decreases the autoimmune burden in Down syndrome

  2024cites this paper
• The SLE‐associated TREX1‐P212fs mutation disrupts ER association leading to type I interferonopathy

  2024cites this paper
• Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation

  2024cites this paper
• Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol

  2023cites this paper
• The role of interferon in the thymus.

  2023cites this paper
• Ocular inflammatory events following COVID-19 vaccination: reporting of suspected adverse drug reactions to regulatory authorities in the UK

  2023cites this paper
• Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis

  2023cites this paper
• Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition

  2023cites this paper
• Interferons as key factors for pathogenesis, diagnostics and treatment

  2023cites this paper
• Modern concept of autoimmunity in rheumatology

  2023cites this paper
• Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research

  2023cites this paper
• Molecular mimicry and autoimmunity in the time of COVID-19

  2023cites this paper
• Regulation of cGAS and STING signaling during inflammation and infection

  2023cites this paper
• Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series

  2023cites this paper
• Interféronopathies de type I : d’un nouveau concept aux thérapeutiques ciblées

  2023cites this paper
• Case report: COPA syndrome with interstitial lung disease, skin involvement, and neuromyelitis spectrum disorder

  2023cites this paper
• Characterization of a mutant samhd1 zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutières syndrome

  2023cites this paper
• Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection.

  2023cites this paper
• JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences

  2023cites this paper
• Multiomics integration of 22 immune-mediated monogenic diseases reveals an emergent axis of human immune health

  2023cites this paper
• Immune-mediated lung diseases: A narrative review

  2023cites this paper
• Type I Interferonopathies in Childhood

  2023cites this paper
• COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis

  2023cites this paper
• Contrasting functions of ATP hydrolysis by MDA5 and LGP2 in viral RNA sensing

  2023cites this paper
• Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model

  2023cites this paper
• Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition

  2023cites this paper
• Type-1 interferon-dependent and -independent mechanisms in cyclic GMP-AMP synthase-stimulator of interferon genes-driven auto-inflammation.

  2023cites this paper
• Activation of Autoreactive Lymphocytes in the Lung by STING Gain-of-function Mutation Radioresistant Cells

  2023cites this paper
• Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)

  2023cites this paper
• Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype

  2023cites this paper
• Ubiquitination network in the type I IFN‐induced antiviral signaling pathway

  2023cites this paper
• What General Neurologists Should Know about Autoinflammatory Syndromes?

  2023cites this paper
• Type I interferon signature and cycling lymphocytes in macrophage activation syndrome

  2023cites this paper
• Breaking down the cellular responses to type I interferon neurotoxicity in the brain

  2023cites this paper
• Treatment of STING-associated vasculopathy with onset in infancy in patients carrying a novel mutation in the TMEM173 gene with the JAK3-inhibitor tofacitinib

  2023cites this paper
• Heterogeneity and functions of the 13 IFN‐α subtypes – lucky for some?

  2023cites this paper
• Yellow catfish RIO kinases (RIOKs) negatively regulate fish interferon-mediated antiviral response.

  2023cites this paper
• Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus

  2022cites this paper
• Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains

  2022cites this paper
• New onset of acute uveitis following COVID-19 vaccination

  2022cites this paper
• Periodic Fever in Children: Etiology and Diagnostic Challenges

  2022influential citation
• ADAR1 averts fatal type I interferon induction by ZBP1

  2022cites this paper
• A Large Cluster of New Onset Autoimmune Myositis in the Yorkshire Region Following SARS-CoV-2 Vaccination

  2022cites this paper
• ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives

  2022cites this paper
• Leveraging Systems Immunology to Optimize Diagnosis and Treatment of Inborn Errors of Immunity

  2022cites this paper
• A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA

  2022cites this paper
• Multiple Evanescent White Dot Syndrome Following COVID-19 mRNA Vaccination

  2022cites this paper